These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28178665)

  • 1. Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients.
    Sharen G; Peng Y; Cheng H; Liu Y; Shi Y; Zhao J
    Oncotarget; 2017 Mar; 8(12):19760-19767. PubMed ID: 28178665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer.
    Yang J; Wen J; Tian T; Lu Z; Wang Y; Wang Z; Wang X; Yang Y
    Oncotarget; 2017 Feb; 8(7):11788-11796. PubMed ID: 28052033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.
    Li CX; Sun JL; Gong ZC; Lin ZQ; Liu H
    Medicine (Baltimore); 2016 Nov; 95(45):e5324. PubMed ID: 27828852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis.
    Pizzi S; Porzionato A; Pasquali C; Guidolin D; Sperti C; Fogar P; Macchi V; De Caro R; Pedrazzoli S; Parenti A
    Histol Histopathol; 2009 Feb; 24(2):175-85. PubMed ID: 19085834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
    Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
    Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis.
    Huang S; Zheng J; Huang Y; Song L; Yin Y; Ou D; He S; Chen X; Ouyang X
    Dis Markers; 2016; 2016():8137378. PubMed ID: 26903691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.
    Zhou S; Wang S; Wu Q; Fan J; Wang Q
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):189-94. PubMed ID: 18401196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
    Davis-Yadley AH; Abbott AM; Pimiento JM; Chen DT; Malafa MP
    Pancreas; 2016 Aug; 45(7):974-9. PubMed ID: 26692443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role of Glucose Transporter-1 Expression in Gastric Cancer: A Meta-Analysis and Systematic Review.
    Tao J; Zhang Y; Wang T
    Iran J Public Health; 2020 Nov; 49(11):2044-2053. PubMed ID: 33708725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
    Deng Y; Zou J; Deng T; Liu J
    Medicine (Baltimore); 2018 Nov; 97(48):e12961. PubMed ID: 30508885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: a meta-analysis.
    Ye LY; Zhang Q; Bai XL; Pankaj P; Hu QD; Liang TB
    Pancreatology; 2014; 14(5):391-7. PubMed ID: 25278309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer.
    Liu Y; Wu T; Lu D; Zhen J; Zhang L
    Int J Biol Markers; 2018 Aug; 33(3):308-313. PubMed ID: 29683068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
    Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
    World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis.
    Ohba S; Fujii H; Ito S; Fujimaki M; Matsumoto F; Furukawa M; Yokoyama J; Kusunoki T; Ikeda K; Hino O
    J Oral Pathol Med; 2010 Jan; 39(1):74-8. PubMed ID: 19709351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
    PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
    Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
    World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.